Home » Newsletters » BioWorld Science

BioWorld Science

May 24, 2017

View Archived Issues

Attune reports preclinical data on ATN-249 for treatment of hereditary angioedema

MATRIX trials reveal postoperative pain reduction with bupivacaine-collagen matrix INL-001

EMA grants orphan drug designation to avacopan for C3 glomerulopathy

Churchill Pharmaceuticals submits NDA for Yonsa

United Neuroscience reports phase I data on UB-311 for Alzheimer's disease

Dose-dependent effects of intranasal oxytocin evaluated in autism spectrum disorders

Global BioLife begins research on universal therapeutic drug platform

DNAnexus partners with AstraZeneca on genomics informatics

MK-7264 shows significant efficacy in patients with refractory chronic cough

FDA grants accelerated approval to Keytruda and priority review for further indication

Imfinzi available in U.S.

GlaxoSmithKline describes novel CPHPC prodrugs

Oryx reports data on ParvOryx combination therapy in GBM

Sutter Health, Dignity Health patent podophyllotoxin and camptothecin derivatives

Calithera Biosciences presents new arginase inhibitors

OSE and Selexis sign commercial license agreement

Northwestern University patents MNK1/2 inhibitors

Palladio Biosciences acquires rights to lixivaptan

WHO Situation Report documents rise in Ebola cases/New antibodies described

Phase III study of Livatag recommended to continue

Debiopharm acquires ImmunoGen's ADC IMGN-529

Spring Bank releases initial cohort data from phase IIa study of SB-9200 in HBV

FDA and EMA accept submissions for UX-003 for mucopolysaccharidosis VII

Neurocrine reports phase II data on Ingrezza in Tourette's syndrome

FDA grants breakthrough therapy designation to plazomicin

Pierre Fabre acquires immuno-oncology assets from Igenica Biotherapeutics

A new zebrafish model of amyotrophic lateral sclerosis shows relevance of the Nefl protein

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...